作者: John Leonard , Sin-Ho Jung , Jeffrey L. Johnson , Nancy Bartlett , Kristie A. Blum
DOI: 10.1200/JCO.2012.30.15_SUPPL.8000
关键词:
摘要: 8000 Background: Lenalidomide (L) and rituximab (R) are active as single agents in follicular (FL) other B-cell lymphomas, although combination strategies have not been previously assessed a...